Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
38.50    0.00 (0.00%)
Bid:
38.34
Ask:
38.48
Spread: 0.14 (0.365%)
Market Cap: £389.89m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Director/PDMR Shareholding

31 Mar 2022 07:00

RNS Number : 6487G
Aston Martin Lagonda Global Hld PLC
31 March 2022
 

31 March 2022

 

 

 

Aston Martin Lagonda Global Holdings plc

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

 

Aston Martin Lagonda Global Holdings plc (the "Company") announces the following transaction by a Director, PDMR and/or person closely associated with them as notified to the Company.

 

 

 

 

 

 

 

 

Enquiries

 

Investors and Analysts

Charlotte Cowley,

Director of Investor Relations

 

 

+44 (0)7771 976764

charlotte.cowley@astonmartin.com

Holly Grainger

Deputy Head Investor Relations

 

+44 (0)7442 989551

holly.grainger@astonmartin.com

Brandon Henderson

Senior Manager, Investor Relations

 

 

+44 (0)7585326704

brandon.henderson@astonmartin.com

Media

Kevin Watters,

Director of Communications 

 

+44 (0)7764 386683

kevin.watters@astonmartin.com

Paul Garbett

Head of Corporate Brand Communications

 

+44 (0)7501 380799

paul.garbett@astonmartin.com

Grace Barnie,

Corporate Communications Manager

 

 +44 (0)7880 903490

grace.barnie@astonmartin.com

Tulchan Communications

Harry Cameron and Simon Pilkington 

 

+44 (0)20 73534200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Lawrence Stroll ("LS")

2

Reason for the notification

a)

Position/status

Executive Chairman of the Company

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aston Martin Lagonda Global Holdings plc

b)

LEI

213800167WOVOK5ZC776

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary shares of £0.10 each in the capital of the Company (the "Shares") (ISIN:GB00N7CG237)

 

 

b)

Nature of the transaction

Previously, on 15 April 2020, Lord Anthony Bamford ("LAB") gave a personal written undertaking to LS that he would exercise all voting rights attaching to the Shares in the Company that LAB holds directly or indirectly from time to time in accordance with LS's written instructions from time to time (the "Original Undertaking").

The Original Undertaking was due to expire on 31 March 2022.

On 30 March 2022, LAB renewed the Original Undertaking by entering into a renewal undertaking which extended the expiry date of the Original Undertaking to the earlier of (i) 31 March 2024; (ii) the date on which LS, directly or indirectly, ceases to hold shares in the Company; and (iii) the date on which LS ceases to be chairman of the Company.

Save for the change in the expiry date, the undertaking remains in force on the same terms as prior to its extension.

c)

Price(s) and volume(s)

Not Applicable

d)

Aggregated information- Aggregated volume- Price

Not Applicable

 

 

 

 

e)

Date of the transaction

30 March 2022

f)

Place of the transaction

Outside a Trading Venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDXUUXDGDG
Date   Source Headline
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance
2nd Aug 20247:00 amRNSAnnouncement of successful private debt placing
24th Jul 20247:02 amRNSConfirmation of start date of new CEO
24th Jul 20247:00 amRNSHalf-year Report
10th Jun 20249:47 amRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSIssue of equity to satisfy employee share awards
8th May 202412:12 pmRNSAGM voting results
2nd May 20244:11 pmRNSDirector/PDMR Shareholding
1st May 20242:59 pmRNSESEF Annual Report 2023
1st May 20247:00 amRNSQ1 results for three months ended 31 March 2024
8th Apr 20249:00 amRNSAnnual Report 2023 and Notice of AGM
28th Mar 20244:10 pmRNSDirector Declaration
22nd Mar 20248:28 amRNSAppointment of New Chief Executive Officer
13th Mar 20246:16 pmRNSSuccessful pricing of £1.15 billion refinancing
12th Mar 20243:33 pmRNSHolding(s) in Company
11th Mar 20247:36 amRNSLaunch of Notes Offering
4th Mar 20249:05 amRNSIssue of equity to satisfy share awards
28th Feb 20247:00 amRNSPreliminary Results year ended 31 December 2023
20th Dec 20239:32 amRNSHolding(s) in Company
20th Dec 20239:31 amRNSHolding(s) in Company
8th Nov 20233:46 pmRNSHolding(s) in Company
8th Nov 20233:41 pmRNSHolding(s) in Company
8th Nov 20238:00 amRNSHolding(s) in Company
7th Nov 20233:23 pmRNSHolding(s) in Company
3rd Nov 202310:18 amRNSDirector/PDMR Shareholding
2nd Nov 20238:00 amRNSAdmission of shares and total voting rights
1st Nov 20237:00 amRNS3rd Quarter Results
30th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20232:14 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:13 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:07 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSIncreased investment by Yew Tree Consortium
19th Sep 202311:53 amRNSResult of Meeting
29th Aug 202312:01 pmRNSPublication of Circular and Notice of GM
4th Aug 20234:45 pmRNSHolding(s) in Company
4th Aug 20231:05 pmRNSDirector/PDMR Shareholding
4th Aug 202312:43 pmRNSDirector/PDMR Shareholding
4th Aug 202312:33 pmRNSDirector/PDMR Shareholding
4th Aug 202312:32 pmRNSDirector/PDMR Shareholding
4th Aug 202312:21 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSResult of Equity Issue
31st Jul 20234:41 pmRNSRetail Offer
31st Jul 20234:40 pmRNSProposed Share Placing
28th Jul 20237:00 amRNSAppointment of Non-executive Director
26th Jul 20232:49 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf-year Report
14th Jul 202312:18 pmRNSHolding(s) in Company
10th Jul 20234:34 pmRNSReplacement Listing and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.